Actionable news
0
All posts from Actionable news
Actionable news in CVS: CVS HEALTH CORPORATION,

CVS Stock Set to Outperform

CVS Health (CVS: NYSE)

By Guggenheim Securities ($79.29, Dec. 28, 2016)

We reiterate our Buy rating, believing CVS Health is poised for outperformance in 2017.

Bottom line: 1) CVS (ticker: CVS) has...


More